nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
|
Roubaud, Guilhem |
|
|
209 |
C |
p. |
artikel |
2 |
An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations
|
Baum, Philip |
|
|
209 |
C |
p. |
artikel |
3 |
Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study
|
Darbandi, Mohammad Reza |
|
|
209 |
C |
p. |
artikel |
4 |
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
|
Mortier, Laurent |
|
|
209 |
C |
p. |
artikel |
5 |
Challenges of estimating treatment effects after a positive interim analysis
|
Soon, Yu Yang |
|
|
209 |
C |
p. |
artikel |
6 |
Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer
|
Cella, Chiara Alessandra |
|
|
209 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
209 |
C |
p. |
artikel |
8 |
Empowering effective biomarker-driven precision oncology: A call to action
|
Lawler, Mark |
|
|
209 |
C |
p. |
artikel |
9 |
Evaluation of a medical student-delivered smoking prevention program utilizing a face-aging mobile app for secondary schools in Germany: The Education Against Tobacco cluster-randomized controlled trial
|
Brinker, Titus J. |
|
|
209 |
C |
p. |
artikel |
10 |
Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors
|
Xie, Mengqing |
|
|
209 |
C |
p. |
artikel |
11 |
Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies
|
Verhaert, Marthe August Marianne |
|
|
209 |
C |
p. |
artikel |
12 |
Integrated nomogram to predict HER2 expression in breast tumor: Clinical, Ultrasound, and Photoacoustic imaging approaches
|
Chen, Jing |
|
|
209 |
C |
p. |
artikel |
13 |
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)
|
Foster, Jennifer H. |
|
|
209 |
C |
p. |
artikel |
14 |
Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer
|
Bollino, Michele |
|
|
209 |
C |
p. |
artikel |
15 |
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
|
Fasching, Peter A. |
|
|
209 |
C |
p. |
artikel |
16 |
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
|
Carrillo-García, Jaime |
|
|
209 |
C |
p. |
artikel |
17 |
Protecting cancer survivors from financial discrimination throughout the EU: A cross-European perspective
|
Meunier, Françoise |
|
|
209 |
C |
p. |
artikel |
18 |
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials
|
Lynch, Connor |
|
|
209 |
C |
p. |
artikel |
19 |
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
|
Mukherjee, Somnath |
|
|
209 |
C |
p. |
artikel |
20 |
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
|
Nasca, Vincenzo |
|
|
209 |
C |
p. |
artikel |
21 |
Systematic nutritional screening and assessment in older patients: Rationale for its integration into oncology practice
|
Bauer, Jürgen M. |
|
|
209 |
C |
p. |
artikel |
22 |
The landscape of checkpoint inhibitors in oncology
|
Haslam, Alyson |
|
|
209 |
C |
p. |
artikel |
23 |
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
|
Ma, Peiwen |
|
|
209 |
C |
p. |
artikel |
24 |
Treating cancer-associated venous thromboembolism: A practical approach
|
Van Cutsem, Eric |
|
|
209 |
C |
p. |
artikel |
25 |
Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
|
Xander, N.S.H. |
|
|
209 |
C |
p. |
artikel |